Journals
Publish with us
Publishing partnerships
About us
Blog
BioMed Research International
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
BioMed Research International
/
2021
/
Article
/
Tab 1
/
Research Article
Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis
Table 1
Binding parameters of selected small drug molecules with TGF-
β
1.
S. No.
Small drug molecules
Target protein
Binding affinity (kcal/mol)
Inhibition constant,
(nM)
1
Silmitasertib
TGF-
β
1
-9.3
1.61889E-06
2
SR10067
-7.8
1.91655E-06
3
Neoruscogenin
-7.5
3.17997E-06
4
SR1078
-7.3
4.45681E-06
5
SRT2183
-7.3
4.45681E-06